|
Table of Contents
|
Shop by Click or Call!
|
|
Visit our Web Site, click direct to a Product (see below), or Call us, toll-free, 7 days a week, 24 hours a day, at 1-800-608-4825.
Wild Seafood
Alaskan Salmon
Smoked Alaskan Salmon
Albacore Tuna (low-mercury, troll-caught)
Alaskan Halibut
Alaskan Scallops
Alaskan Sablefish (Black Cod)
Alaskan Red King Crab
Pacific Spot Prawns
Salmon Sausage & Burgers
Yukon King Salmon "Candy"
Salmon Caviar (Ikura)
Canned Salmon, Tuna, & Sardines
Salmon Dog Treats
Sockeye Salmon Oil
Capsules or Liquid
Organic Foods
Organic Nuts
Organic Dried Fruits
Organic Berries
Organic Chocolate
Artisan Teas
Organic Seasonings
Organic EV Olive and Macadamia Oils
Gifts
Gift Certificates
Gift Packs
Sampler Packs, Specials, Extras
Dr. Perricone Pack
Dr. Northrup Mom-Baby Pack
Sampler Packs
Special Offers
BBQ Planks
Cookbooks
To get a free catalog, click here, or call us toll-free at 1-800-608-4825.
|
|
|
Superb, Extra-SafeTuna
|
|
Our young, low-weight Pacific Albacore Tuna—whether Flash-Frozen or Canned—is safer and superior!
Smaller means safer: Vital Choice troll-caught Albacore Tuna weigh just 12 lbs. or less, so they contain much less mercury, and more omega-3s, than the far larger, older Tuna canned by national brands and served in sushi bars.
Better, fresher flavor, even in the can: Unlike standard canned Albacore—which is cooked twice at great cost to its flavor and omega-3 content—Vital Choice Albacore Tuna is cooked only once (in the can) to preserve its healthful oils and fresh flavor. Choose from Regular or No Salt Added.
No loitering allowed: Our tuna are hauled in fast, bled, and flash-frozen within about two hours. (The standard long-line-caught Tuna canned by national brands spend 12 hours in the water.)
|
|
|
Get HealthWise ... and Save!
|
|
Earn rewards with our popular HealthWise “frequent shopper” rewards program … the more you spend, the more you get back!
Now, you can enroll anytime, and as always, it’s free!
To see how it works, click HERE.
|
|
|
Many Fishermen's Favorite Salmon
|
|
Our wild Alaskan Sockeye Salmon offers special appeal to those—like many of us here at Vital Choice—who like their wild salmon firm and flavorful.
These sustainably harvested fish are a super-healthy source of protein, rich in long-chain omega-3 essential fatty acids, and potent natural antioxidants.
And sockeye is a nearly unrivalled food source of bone-saving, cancer-curbing vitamin D, with a whopping 1,100 IU per 6-oz serving, or nearly triple the US RDA.
Our flash-frozen portions come vacuum-sealed for superior quality and convenience. Certified Kosher by EarthK
|
|
|
Wild Alaskan Scallops ... Sweet and Sustainable!
|
|
People seem to swoon over our sweet, succulent, sustainably harvested Alaska weathervane scallops.
Unlike common farmed varieties, Vital Choice scallops grow as nature intended in the cold, clear waters near Kodiak Island, Alaska.
They're individually quick frozen and available in convenient re-sealable bags, so that you can take only the scallops you need and return the rest to the freezer.
|
|
|
World's Best Canned Salmon
|
|
If you haven't tried our Wild Red Sockeye Salmon you're in for a treat, because it tastes much fresher and firmer than standard supermarket brands.
The rich, red color of the meat and oil is unlike any you're likely to have had before. And minimal processing ensures that you'll get the maximum amount of nutrients naturally abundant in Sockeye Salmon: omega-3s, vitamin D, and astaxanthin (a potent orange-red antioxidant pigment).
Choose Skinless-Boneless Wild Red, or Traditional Style with skin and soft edible bones for extra flavor and ample calcium.
Both kinds are available with or without added salt ... and several varieties come in EZ-Open pull-tab tops.
“You are providing a wonderful health-giving service to the planet with your business. And it is a pleasure to bring this information to my audience. It is also a pleasure to snap open these little cans of salmon and have an instant healthy meal!”
-- Dr. Christiane Northrup
|
|
|
The Chocolate of Fish!
|
|
Sablefish is rarely seen in standard fish markets, but this buttery, flaky, white fish boasts its own rich texture and mind-blowing flavor ... and even more omega-3s than wild Salmon!
In addition to our certified Earth Kosher Sablefish, we feature golden Oven-Ready Smoked Sablefish: scrumptious, steaks infused with delicate alder wood smoke flavor, which cook fully from frozen in just a few minutes.
|
|
|
Light, Luscious Alaskan Halibut
|
|
Our Alaskan halibut is light and lean with a wonderful flavor and texture. With longer-lived predatory fish like halibut and tuna, age and purity go hand in hand--the younger and smaller the fish, the purer it will be.
Vital Choice offers you the peace of mind of knowing that you're buying the purest halibut available by procuring only the smallest, sustainably-harvested fish (unlike store or restaurant bought halibut--where it's almost impossible to know what you're getting.)
Save on our Halibut by choosing our vacuum-sealed 2-lb. packages of smaller pieces, frozen together in one solid block. They're an excellent value, and great for quick, healthy stir-fries, fish tacos, sashimi or sushi rolls.
"Absolutely delicious! My kids devoured every morsel of the halibut and have asked me to order more. Thank you for sharing your wonderful secret with us."
-- Michele S. Cook of Lake City, Florida
|
|
|  |
|
|
Cholesterol Fiasco Undermines Accepted Theory
Counterintuitive outcome of cholesterol drug trial prompts renewed scrutiny of cholesterol’s role in heart disease.
by Craig Weatherby
Last month, we reported on the unexpected outcome of a study that tested the effects of Vytorin: a drug that combines two cholesterol-lowering medications of different types.
Vytorin contains both Zocor (simivistatin) – a statin-type drug that reduces the body’s production of cholesterol – and Zetia: a non-statin drug that reduces absorption of cholesterol from foods.
The clinical trial – whose negative outcome the makers of Vytorin seemed suspiciously slow to reveal – showed that the combination drug did no better than Zocor alone: see “Major Heart and Mood Drugs Take Huge Credibility Hits”.
There is clinical evidence that Zocor – unlike some other statins and unlike Zetia – reduces the risk of heart attacks and other adverse cardiac events.
But a key question remains unanswered: Do statins bring these benefits by lowering cholesterol, or by other means, such as their ability to reduce inflammation markers associated with risk of adverse cardiac events?
As it should have, the surprising outcome of the Vytorin trial led to a series of newspaper stories on the increasingly shaky foundations of the cholesterol theory of cardiovascular disease (CVD).
Rather than make a case for or against the cholesterol theory of CVD, we'd like to direct you to the responses the Vytorin affair elicited from health writers at two major newspapers: The New York Times and The Boston Globe (see links below).
Cholesterol theory's weak underpinnings
The cholesterol hypothesis – whose lack of conclusive evidence argues against it even being called a theory –holds that high levels of cholesterol (especially LDL and VLDL cholesterol) – cause CVD.
In fact, the evidence that elevated cholesterol causes CVD has never enjoyed direct cause-effect evidence.
Instead, the hypothesis has been based on the kinds of correlations (statistical associations) that official bodies dismiss as inconclusive in all other contexts ... including the potential roles of nutrients and antioxidants in disease prevention.
Despite this lack of solid cause-effect evidence for the cholesterol hypothesis of CVD, the US FDA automatically allows disease-prevention claims for any drug – such as Zetia – proven to lower cholesterol.
Incredibly, the agency allows therapeutic claims for cholesterol-lowering drugs ... even drugs never proven to prevent major symptoms of CVD (e.g., buildup of arterial plaque) or its deadly outcomes, such as stroke, heart attacks, congestive heart failure, and sudden death.
(Sadly, fish oil does enjoy such evidence, but as a non-patentable natural product, it is unlikely to ever get the funding necessary to get it through the nearly $1 billion drug approval process.)
The aforementioned articles – four from The New York Times and one from The Boston Globe – are presented here in order of publication date:
- “What That Cholesterol Trial Didn’t Show” by Tara Parker-Pope. The New York Times, January 22, 2008.
- “What’s Cholesterol Got to Do With It?” by Gary Taubes. The New York Times, January 22, 2008
- “Will Cholesterol Pills Save Your Life?” by Tara Parker-Pope. The New York Times, January 28, 2008.
- “Great Drug, but Does It Prolong Life?” by Tara Parker-Pope. The New York Times, January 29, 2008.
- “No Easy Answers: Even in the age of statins, heart disease threat remains” by Stephen Smith. The Boston Globe, February 11, 2008
We think you will find these writers' analyses informative and thought-provoking.
[PRINTER FRIENDLY VERSION]
|
|
|
